Experimental allergic encephalomyelitis: A misleading model of multiple sclerosis

被引:197
作者
Sriram, S
Steiner, I
机构
[1] Vanderbilt Univ Sch Med, Dept Neurol, Nashville, TN USA
[2] Hadassah Univ Hosp, Dept Neurol, IL-91120 Jerusalem, Israel
关键词
D O I
10.1002/ana.20743
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Despite many years of intensive research, multiple sclerosis (MS) defies understanding and treatment remains suboptimal. The prevailing hypothesis is that MS is immune mediated and that experimental allergic encephalomyelitis (EAE) is a suitable model to elucidate pathogenesis and devise therapy. This review examines critically the validity that EAE is an adequate and useful animal model of MS and finds credible evidence lacking. EAE represents more a model of acute central nervous system inflammation than the counterpart of MS. We propose to reconsider the utilization of EAE, especially when this model is used to define therapy. This will also force us to examine MS without the restraints imposed by EAE, as to what it is, rather than what it looks like.
引用
收藏
页码:939 / 945
页数:7
相关论文
共 78 条
[1]
Functional diversity of helper T lymphocytes [J].
Abbas, AK ;
Murphy, KM ;
Sher, A .
NATURE, 1996, 383 (6603) :787-793
[2]
[Anonymous], COCHRANE DATABASE SY, DOI 10.1002/14651858.CD004678
[3]
[Anonymous], ALLERGIC ENCEPHALOMY
[4]
Clonal expansions of CD8+ T cells dominate the T cell infiltrate in active multiple sclerosis lesions as shown by micromanipulation and single cell polymerase chain reaction [J].
Babbe, H ;
Roers, A ;
Waisman, A ;
Lassmann, H ;
Goebels, N ;
Hohlfeld, R ;
Friese, M ;
Schröder, R ;
Deckert, M ;
Schmidt, S ;
Ravid, R ;
Rajewsky, K .
JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 192 (03) :393-404
[5]
Badmaev V, 1999, PHYTOTHER RES, V13, P218, DOI 10.1002/(SICI)1099-1573(199905)13:3&lt
[6]
218::AID-PTR426&gt
[7]
3.0.CO
[8]
2-D
[9]
Relapsing and remitting multiple sclerosis: Pathology of the newly forming lesion [J].
Barnett, MH ;
Prineas, JW .
ANNALS OF NEUROLOGY, 2004, 55 (04) :458-468
[10]
GAMMA-INTERFERON INDUCTION IN PATIENTS WITH CHRONIC PROGRESSIVE MS [J].
BEVER, CT ;
PANITCH, HS ;
LEVY, HB ;
MCFARLIN, DE ;
JOHNSON, KP .
NEUROLOGY, 1991, 41 (07) :1124-1127